The impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection in Alberta: A model-based analysis
This is the first study to estimate CHC prevalence and undiagnosed proportions in Alberta using provincial health administrative data. These results could provide vital evidence to guide decisions about current and future hepatitis C virus strategies and help achieve the World Health Organization goal of eliminating hepatitis C in Canada by 2030.
Authors
- William W. L. Wong (ORCID: https://orcid.org/0000-0003-4630-0052)
- Fiona Clement (ORCID: https://orcid.org/0000-0003-0209-9457)
- N Eze (ORCID: https://orcid.org/0000-0003-0749-4915)
- Diedron Lewis (ORCID: https://orcid.org/0009-0003-4227-7550)
- Farinaz Forouzannia (ORCID: https://orcid.org/0000-0003-1833-823X)
Institutions
- University of Waterloo (CA)
- University of Calgary (CA)
Publication Details
- Journal
- Canadian Liver Journal
- Published
- 2025-04-14
- DOI
- https://doi.org/10.3138/canlivj-2024-0062
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00